Surgical glue is being applied in ample quantities in plastic surgeries, which are on the rise due to the technological developments in surgical procedures, surging disposable income, and increasing consciousness among consumers regarding their appearance. According to the International Society of Aesthetic Plastic Surgery (ISAPS), the top five cosmetic surgeries include breast augmentation, liposuction, eyelid surgery, abdominoplasty, and rhinoplasty.
Medical facilities use different types of surgical adhesives and sealants for sealing the wounds caused by injury and surgery. In recent years, the demand for fibrin sealant has surged rapidly due to its natural origin and growing consumption in multiple procedures. Fibrin sealants are more compatible with the human body, as they are derived from animal or human blood cells. Additionally, medical professionals are adopting cyanoacrylate for the adhesion and repair of blood vessels and tissues, surgical incisions, plastic surgeries, and ophthalmic procedures, due to its strength, durability, and waterproof characteristics.
Surgical glue is mostly used in hospitals, in complex surgeries, such as pulmonary, vascular, and cardia, along with numerous other procedures. among the various surgical procedures, the glue is used in the highest volumes in cardiac surgeries. Owing to the increasing prevalence of cardiac diseases, the number of surgeries is also on the rise. According to the World Health Organization (WHO), CVDs cause more than 17.9 million deaths yearly and account for around 31% of the deaths globally. Further, the WHO projects that the number of CVD deaths will reach around 23.6 million by 2030.
Thus, with the increase in the prevalence of chronic diseases and awareness regarding appearance, there has been an escalation in the number of surgical procedures. To cater to the burgeoning surgical glue demand as a result, players in the surgical glue market, such as Advanced Medical Solutions Group PLC, Baxter International Inc., Cardinal Health Inc., Integra LifeSciences Holdings Corporation, Medtronic PLC, C. R. Bard Inc., Braun Melsungen AG, and Takeda Pharmaceutical Company Limited, are producing these surgical adhesives and sealants in large quantities.
Geographically, North America will continue to consume the highest volume of surgical glue in the coming years due to the growth in investments in research and development (R&D) for medical adhesives and rise in the number of surgical procedures. Furthermore, the Asia-Pacific (APAC) region is witnessing a rapid adoption of the glue due to a surge in the aging population, growth in the incidence of road accidents and burns, and hike in the per capita income. The elderly are more susceptible to chronic diseases and require longer to recover, thereby leading to the usage of large quantities of surgical glue.
Thus, the rising volume of surgeries, as a result of the increase in the prevalence of various acute and chronic diseases, rising number of accidents, and increasing appearance consciousness is driving the demand for surgical glue.